829
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Molecular determination of insect venom allergies

ORCID Icon, , &
Pages 983-986 | Received 27 Sep 2022, Accepted 25 Nov 2022, Published online: 29 Nov 2022

References

  • Blank S, Pehlivanli S, Methe H, et al. Fatal anaphylaxis following a hornet sting in a yellow jacket venom-sensitized patient with undetected monoclonal mast cell activation syndrome and without previous history of a systemic sting reaction. J Allergy Clin Immunol Pract. 2020;8(1):401–403 e402.
  • Blank S, Haemmerle S, Jaeger T, et al. Prevalence of Hymenoptera venom allergy and sensitization in the population-representative German KORA cohort. Allergo J Int. 2019;28(6):183–191.
  • Sturm GJ, Varga EM, Roberts G, et al. EAACI guidelines on allergen immunotherapy: hymenoptera venom allergy. Allergy. 2018;73(4):744–764.
  • Worm M, Moneret-Vautrin A, Scherer K, et al. First European data from the network of severe allergic reactions (NORA). Allergy. 2014;69(10):1397–1404.
  • Blank S, Bilo MB, Ollert M. Component-resolved diagnostics to direct in venom immunotherapy: important steps towards precision medicine. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology. 2018;48(4):354–364.
  • Muller UR, Johansen N, Petersen AB, et al. Hymenoptera venom allergy: analysis of double positivity to honey bee and Vespula venom by estimation of IgE antibodies to species-specific major allergens Api m1 and Ves v5. Allergy. 2009;64(4):543–548.
  • Blank S, Bilò MB, Grosch J, et al. Marker allergens in Hymenoptera venom allergy — characteristics and potential use in precision medicine. Allergo J Int. 2021;30(1):26–38.
  • Kosnik M, Korosec P, Silar M, et al. Wasp venom is appropriate for immunotherapy of patients with allergic reaction to the European hornet sting. Croat Med J. 2002;43(1):25–27.
  • Macchia D, Cortellini G, Mauro M, et al. Vespa crabro immunotherapy versus Vespula-venom immunotherapy in Vespa crabro allergy: a comparison study in field re-stings. World Allergy Organ J. 2018;11(1):3.
  • Jappe U, Raulf-Heimsoth M, Hoffmann M, et al. In vitro hymenoptera venom allergy diagnosis: improved by screening for cross-reactive carbohydrate determinants and reciprocal inhibition. Allergy. 2006;61(10):1220–1229.
  • Blank S, Grosch J, Ollert M, et al. Precision medicine in hymenoptera venom allergy: diagnostics, biomarkers, and therapy of different endotypes and phenotypes. Front Immunol. 2020;11:579409.
  • Kohler J, Blank S, Muller S, et al. Component resolution reveals additional major allergens in patients with honeybee venom allergy. J Allergy Clin Immunol. 2014;133(5):1383–1389, 1389 e1381–1386.
  • Frick M, Fischer J, Helbling A, et al. Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy. J Allergy Clin Immunol. 2016;138(6):1663–1671 e1669.
  • Jakob T, Rauber MM, Perez-Riverol A, et al. The honeybee venom major allergen Api m 10 (Icarapin) and its role in diagnostics and Treatment of hymenoptera venom allergy. Curr Allergy Asthma Rep. 2020;20(9):48.
  • Blank S, Etzold S, Darsow U, et al. Component-resolved evaluation of the content of major allergens in therapeutic extracts for specific immunotherapy of honeybee venom allergy. Hum Vaccin Immunother. 2017;13(10):2482–2489.
  • Ruiz B, Serrano P, Moreno C. IgE-Api m 4 is useful for identifying a particular phenotype of bee venom allergy. J Investig Allergol Clin Immunol. 2016;26(6):355–361.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.